Highlights

  • Revenue rose 283 per cent, almost all of it from the Defence Systems division, where sales of $163.7 million were up 322 per cent.
  • Space Systems, the smaller arm, recorded Revenue of $5.1 million, down 4 per cent.
  • Underlying EBITDA from continuing operations was a $21.6 million profit in the first half of 2026.
  • The net loss attributable to members was $32.9 million for the first half of 2026.
  • The main driver was a non-cash $34.0 million Fair Value charge on the contingent consideration owed for the MARSS acquisition.

Electro Optic Systems Holdings Limited (ASX:EOS) develops defence technologies including remote weapon systems, counter-drone systems and space observation capabilities. Its first-half 2026 results reflected increased Defence Systems deliveries and a larger order book, while Acquisition accounting, Working Capital and contract execution remained material considerations.

The order book and guidance

The order book is the centre of the case. Management put contracted orders at about $846 million, made up of roughly $605 million of unconditional Defence orders excluding MARSS and about $225 million from MARSS.

MARSS and the Middle East opportunity

In May 2026 EOS completed its acquisition of MARSS Group, now integrated into Defence Systems. The deal created the earn-out Liability behind the large non-cash charge. The first earn-out Tranche was confirmed after qualifying orders of EUR 120.3 million, implying about EUR 24.06 million of value, which vendors can take as up to EUR 20.0 million in cash with the balance in shares.

Funding and balance sheet

Growth has been funded in part by shareholders and in part by debt. EOS raised $190 million of Equity and arranged a $100 million term Loan from Washington H. Soul Pattinson, of which $70 million was drawn at balance date. The Facility matures on 28 February 2028 and carries an average all-in rate of 14.75 per cent, a high Cost of Capital that reflects the company's history.

What to watch

Several items will determine whether the numbers hold. First, whether the Middle East contract is signed and on what terms. Second, whether second-half revenue reaches the $360 million to $400 million range given supply-chain exposure. Third, whether gross margins stabilise as volumes rise. Fourth, how the MARSS earn-out is settled, in cash or shares, and its effect on dilution.

Key Insights

Several items will determine whether the numbers hold. First, whether the Middle East contract is signed and on what terms. Second, whether second-half revenue reaches the $360 million to $400 million range given supply-chain exposure. Third, whether gross margins stabilise as volumes rise. Fourth, how the MARSS earn-out is settled, in cash or shares, and its effect on dilution.